Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GenScript

GenScript
2002 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
01548 STOCK SYMBOL
2 INVESTMENTS
$2.33 SHARE PRICE (As of Wednesday Closing)
Description

Genscript Biotech Corp an investment holding company. It is involved in fundamental life sciences research, translational biomedical research, and early-stage pharmaceutical development businesses. The company segments include bio-science services and products, biologics development services, industrial synthetic biology products, and cell therapy. It generates maximum revenue from the bio-science services and products. Geographically, it derives majority revenue from North America and also has a presence in Europe, China, Asia Pacific, Japan, and Other Countries.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
HKG
Primary Office
  • 860 Centennial Avenue
  • Piscataway Township, NJ 08854
  • United States

+1 (877) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GenScript’s full profile, request a free trial.

GenScript Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.20 - $3.12 $4.34B $2.37 -$0.01 5.22M 1.86B

GenScript Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 4,114,329 2,010,503 4,279,665 681,769
Revenue 240,674 231,017 152,649 114,735
EBITDA (29,159) 25,682 44,664 37,633
Net Income (21,649) 21,216 26,123 26,170
Total Assets 881,952 916,976 504,264 226,032
Total Debt 24,683 10,502 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GenScript Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore GenScript‘s full profile, request access.

Request full access to PitchBook

GenScript Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
JPT Peptides Technologies (BioNTech) Corporation Acton, MA
0000 000000000 000 Corporation Danvers, MA
0000000 0000000000 Formerly PE-Backed Baltimore, MD 000 000.00 000000&0 000.00
00000 0000000000 Formerly VC-backed San Francisco, CA 000 00000 00000000 00000
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

GenScript Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 11-Jan-2018 000000000000000000 Biotechnology 00000 00000 00.0
Bestzyme Bio-Engineering 07-Apr-2016 Merger/Acquisition 00.000 Biotechnology 000000000 00000
To view this company’s complete investment and acquisition history, request access »

GenScript Subsidiaries (2)

Company Name Industry Location Founded
Bestzyme Bio-Engineering Biotechnology Jinan, China 2009
00000000000 Biotechnology Bothell, WA 0000
To view this company’s complete subsidiary history, request access »

GenScript Executive Team (21)

Name Title Board
Seat
Contact
Info
Fangliang Zhang Co-Founder, Chairman & Chief Executive Officer
Frank Zhang Ph.D Chief Executive Officer
Larry Wang Ph.D President
Sally Wang Executive Vice President & Chief Operating Officer
Zhenyu Liu Ph.D General Manager

2 Former Executives

You’re viewing 5 of 21 executives. Get the full list »

GenScript Board Members (2)

Name Representing Role Since Contact
Info
Fangliang Zhang GenScript Co-Founder, Chairman & Chief Executive Officer 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »